A leadless pacemaker (100, 200, 300) and trailing (1, 3, 5) and leading (2, 4, 6) components thereof are disclosed. The trailing component (1, 3, 5) includes a first connecting member (12, 32) and a second connecting member (13), and the leading component (2, 4, 6) includes a third connecting member (23, 42, 62) and a fourth connecting member (24, 63). The first connecting member (12, 32) is configured to be detachably connected to the third connecting member (23, 42, 62) and the second connecting member (13) is configured to be detachably or non-detachably connected to the fourth connecting member (24, 63), thereby achieving interlocking between the trailing component (1, 3, 5) and the leading component (2, 4, 6). Additionally, both the first connecting member (12, 32) and the third connecting member (23, 42, 62) are non-biodegradable. At least one of the second connecting member (13) and the fourth connecting member (24, 63) is biodegradable, or the second connecting member (13) is fitted and connected to the fourth connecting member (24, 63) by an associated biodegradable connecting member. Thus, before the connecting member is degraded, it can be ensured that the trailing component (1, 3, 5) and the leading component (2, 4, 6) are firmly connected together by the four connecting members, facilitating overall retrieval or adjustment of the pacemaker (100, 200, 300). Moreover, after the connecting member is degraded, the trailing component (1, 3, 5) can be easily retrieved.

A leadless pacemaker (100, 200, 300) and trailing (1, 3, 5) and leading (2, 4, 6) components thereof are disclosed. The trailing component (1, 3, 5) includes a first connecting member (12, 32) and a second connecting member (13), and the leading component (2, 4, 6) includes a third connecting member (23, 42, 62) and a fourth connecting member (24, 63). The first connecting member (12, 32) is configured to be detachably connected to the third connecting member (23, 42, 62) and the second connecting member (13) is configured to be detachably or non-detachably connected to the fourth connecting member (24, 63), thereby achieving interlocking between the trailing component (1, 3, 5) and the leading component (2, 4, 6). Additionally, both the first connecting member (12, 32) and the third connecting member (23, 42, 62) are non-biodegradable. At least one of the second connecting member (13) and the fourth connecting member (24, 63) is biodegradable, or the second connecting member (13) is fitted and connected to the fourth connecting member (24, 63) by an associated biodegradable connecting member. Thus, before the connecting member is degraded, it can be ensured that the trailing component (1, 3, 5) and the leading component (2, 4, 6) are firmly connected together by the four connecting members, facilitating overall retrieval or adjustment of the pacemaker (100, 200, 300). Moreover, after the connecting member is degraded, the trailing component (1, 3, 5) can be easily retrieved.

A method and apparatus for treatment of heart failure by increasing secretion of endogenous naturetic hormones ANP and BNP such as by stimulation of the heart atria. Heart pacing is done at an atrial contraction rate that is increased and can be higher than the ventricular contraction rate. Pacing may include mechanical distension of the right atrial appendage. An implantable device is used to periodically cyclically stretch the walls of the appendage with an implanted balloon.

An implantable medical device (IMD) and method are provided. The IMD includes a sensing channel configured to obtain biological signals indicative of biological behavior of an anatomy of interest over a period of time. The biological behavior has a feature of interest that repeats over time. The biological signals have clinically relevant (CR) segments that include information related to the feature of interest. The biological signals have non-clinically relevant (NCR) segments that do not include information related to the feature of interest. At least one of circuitry or a processor are configured to compare the biological signals to an amplitude window to distinguish the CR segments from the NCR segments, save to memory the CR segments and delete the NCR segments, save to memory time information indicative of a duration of the NCR segments that were deleted and to form a lossy compressed data set for the biological signals.

An implantable medical device (IMD) and method are provided. The IMD includes a sensing channel configured to obtain biological signals indicative of biological behavior of an anatomy of interest over a period of time. The biological behavior has a feature of interest that repeats over time. The biological signals have clinically relevant (CR) segments that include information related to the feature of interest. The biological signals have non-clinically relevant (NCR) segments that do not include information related to the feature of interest. At least one of circuitry or a processor are configured to compare the biological signals to an amplitude window to distinguish the CR segments from the NCR segments, save to memory the CR segments and delete the NCR segments, save to memory time information indicative of a duration of the NCR segments that were deleted and to form a lossy compressed data set for the biological signals.

Systems and methods can be used to provide an indication of heart function, such as an indication of mechanical function or hemodynamics of the heart, based on electrical data. For example, a method for assessing a function of the heart can include determining a time-based electrical characteristic for a plurality of points distributed across a spatial region of the heart. The plurality of points can be grouped into at least two subsets of points based on at least one of a spatial location for the plurality of points or the time-based electrical characteristics for the plurality of points. An indication of synchrony for the heart can be quantified based on relative analysis of the determined time-based electrical characteristic for each of the at least two subsets of points.

Systems and methods can be used to provide an indication of heart function, such as an indication of mechanical function or hemodynamics of the heart, based on electrical data. For example, a method for assessing a function of the heart can include determining a time-based electrical characteristic for a plurality of points distributed across a spatial region of the heart. The plurality of points can be grouped into at least two subsets of points based on at least one of a spatial location for the plurality of points or the time-based electrical characteristics for the plurality of points. An indication of synchrony for the heart can be quantified based on relative analysis of the determined time-based electrical characteristic for each of the at least two subsets of points.

The present disclosure relates to a system for generating a predefined electrical signal in an MR scanner for use in electrical stimulation of a subject during MRI or functional MRI of said subject, wherein said MR scanner is located inside a shielded MRI room. The system comprises a control unit to be located outside the MRI room for generating an electrical signal and an electrical to optical converter to be located outside the MRI room for converting said electrical signal to a corresponding optical signal. An optical transmitting element, such as an optical fiber, is used for transmitting the optical signal into the MRI room, and an optical to electrical converter is used for converting the optical signal to said predefined electrical signal for electrical stimulation of the subject during magnetic resonance imaging. The optical to electrical converter is configured for being located inside the MRI room and for operation during magnetic resonance imaging.

An exemplary system includes a coil configured to be positioned over a wound on a body and held in place on the body by a magnet implanted within the body. The system further includes a controller communicatively coupled to the coil and configured to apply therapeutic electromagnetic pulses by way of the coil to the wound. Other systems and methods for providing therapeutic electromagnetic pulses to a recipient are also disclosed.

A system includes a signal generator, configured to pass a generated signal, which has two different generated frequencies, through a circuit including an intrabody electrode. The system further includes a processor, configured to identify, while the generated signal is passed through the circuit, a derived frequency, which is derived from the generated frequencies, on the circuit, and to generate, in response to identifying the derived frequency, an output indicating a flaw in the electrode. Other embodiments are also described.